Unsupervised hierarchical clustering analysis of procured tumor samples of known IHC subtype suggested this assay can efficiently group breast tumor samples into the three major subtypes of hormone receptor positive, HER2+ and triple negative breast cancer. This evidence concerns the gene ERBB2 and breast neoplasm.